CardioCare (New Forest) Limited 13667203 false 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true 13667203 2023-10-01 2024-09-30 13667203 2024-09-30 13667203 core:AcceleratedTaxDepreciationDeferredTax 2024-09-30 13667203 core:CurrentFinancialInstruments 2024-09-30 13667203 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 13667203 core:ConstructionInProgressAssetsUnderConstruction 2024-09-30 13667203 core:FurnitureFittingsToolsEquipment 2024-09-30 13667203 bus:SmallEntities 2023-10-01 2024-09-30 13667203 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 13667203 bus:FilletedAccounts 2023-10-01 2024-09-30 13667203 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 13667203 bus:RegisteredOffice 2023-10-01 2024-09-30 13667203 bus:Director1 2023-10-01 2024-09-30 13667203 bus:Director2 2023-10-01 2024-09-30 13667203 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 13667203 core:ConstructionInProgressAssetsUnderConstruction 2023-10-01 2024-09-30 13667203 core:FurnitureFittingsToolsEquipment 2023-10-01 2024-09-30 13667203 core:OfficeEquipment 2023-10-01 2024-09-30 13667203 core:PlantMachinery 2023-10-01 2024-09-30 13667203 countries:EnglandWales 2023-10-01 2024-09-30 13667203 2023-09-30 13667203 core:ConstructionInProgressAssetsUnderConstruction 2023-09-30 13667203 core:FurnitureFittingsToolsEquipment 2023-09-30 13667203 2022-10-01 2023-09-30 13667203 2023-09-30 13667203 core:AcceleratedTaxDepreciationDeferredTax 2023-09-30 13667203 core:TaxLossesCarry-forwardsDeferredTax 2023-09-30 13667203 core:CurrentFinancialInstruments 2023-09-30 13667203 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 13667203 core:ConstructionInProgressAssetsUnderConstruction 2023-09-30 13667203 core:FurnitureFittingsToolsEquipment 2023-09-30 iso4217:GBP xbrli:pure

Registration number: 13667203

Prepared for the registrar

CardioCare (New Forest) Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 September 2024

 

CardioCare (New Forest) Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

CardioCare (New Forest) Limited

Company Information

Directors

I Johnson

V Johnson

Registered office

Orchard House
Wilverley Road
Brockenhurst
Hampshire
SO42 7SP

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

CardioCare (New Forest) Limited

(Registration number: 13667203)
Balance Sheet as at 30 September 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

23,581

29,064

Current assets

 

Stocks

158

201

Debtors

5

3,690

2,290

Cash at bank and in hand

 

30,573

44,668

 

34,421

47,159

Creditors: Amounts falling due within one year

6

(31,918)

(64,898)

Net current assets/(liabilities)

 

2,503

(17,739)

Total assets less current liabilities

 

26,084

11,325

Deferred tax liabilities

7

(4,480)

(1,689)

Net assets

 

21,604

9,636

Capital and reserves

 

Called up share capital

9

100

100

Retained earnings

21,504

9,536

Shareholders' funds

 

21,604

9,636

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 16 January 2025 and signed on its behalf by:
 


I Johnson
Director


V Johnson
Director

 

CardioCare (New Forest) Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Orchard House
Wilverley Road
Brockenhurst
Hampshire
SO42 7SP

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

CardioCare (New Forest) Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilites and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

33.3% straight line

Plant and machinery

25% of written down value

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

 

CardioCare (New Forest) Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.


Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.


Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

 

CardioCare (New Forest) Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

 

4

Tangible assets

Office equipment
 £

Plant and machinery
 £

Total
£

Cost

At 1 October 2023

2,328

48,694

51,022

Additions

916

2,040

2,956

At 30 September 2024

3,244

50,734

53,978

Depreciation

At 1 October 2023

653

21,305

21,958

Charge for the year

1,081

7,358

8,439

At 30 September 2024

1,734

28,663

30,397

Carrying amount

At 30 September 2024

1,510

22,071

23,581

At 30 September 2023

1,675

27,389

29,064

 

5

Debtors

2024
£

2023
£

Trade debtors

3,204

1,824

Prepayments

285

265

Other debtors

201

201

3,690

2,290

 

CardioCare (New Forest) Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

 

6

Creditors

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

8

20,499

54,267

Trade creditors

 

207

138

Taxation and social security

 

4,232

2,061

Accruals and deferred income

 

6,980

8,432

 

31,918

64,898

 

7

Deferred tax

Deferred tax assets and liabilities

2024

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

4,480

4,480

2023

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

7,266

Losses and other deductions

(5,577)

1,689

 

8

Loans and borrowings

Current loans and borrowings

2024
£

2023
£

Other borrowings

20,499

54,267

 

9

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary A shares of £1 each of £1 each

50

50

50

50

Ordinary B shares of £1 each of £1 each

50

50

50

50

 

100

100

100

100

The different classes of shares referred to above carry separate rights to dividends but, in all other significant respects, rank pari passu.